These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 8548608

  • 21. [The neuroleptic malignant syndrome].
    Till E, Vucković S, Lisulov R, Nedić A.
    Med Pregl; 1989; 42(11-12):419-23. PubMed ID: 2701889
    [Abstract] [Full Text] [Related]

  • 22. Neuroleptic malignant syndrome: a case report.
    Fekadu A, Wakwoya A.
    Ethiop Med J; 1999 Jul; 37(3):195-8. PubMed ID: 11957317
    [Abstract] [Full Text] [Related]

  • 23. Classification system of complications in neuroleptic malignant syndrome.
    Taniguchi N, Tanii H, Nishikawa T, Miyamae Y, Shinozaki K, Inoue Y, Morihara T, Nakano Y, Nishimura T, Takeda M.
    Methods Find Exp Clin Pharmacol; 1997 Apr; 19(3):193-9. PubMed ID: 9203169
    [Abstract] [Full Text] [Related]

  • 24. Clinical risk factors for neuroleptic malignant syndrome.
    Berardi D, Dell'Atti M, Amore M, De Ronchi D, Ferrari G.
    Hum Psychopharmacol; 2002 Mar; 17(2):99-102. PubMed ID: 12404699
    [Abstract] [Full Text] [Related]

  • 25. [Neuroleptic malignant syndrome. Analysis of 9 cases].
    Rivera JM, García-Bragado F, Iriarte LM, Lozano Gutiérrez F, Salgado V, Andreu J, Moriñigo A.
    Med Clin (Barc); 1990 Feb 03; 94(4):121-5. PubMed ID: 2325462
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD, Pedersen S.
    Ugeskr Laeger; 2000 Mar 06; 162(10):1366-70. PubMed ID: 10745673
    [Abstract] [Full Text] [Related]

  • 28. Neuroleptic malignant syndrome related to use of clozapine.
    Trayer JS, Fidler DC.
    J Am Osteopath Assoc; 1998 Mar 06; 98(3):168-9. PubMed ID: 9558834
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Hypophosphatemia and neuroleptic malignant syndrome.
    Seitz DP.
    J Clin Psychopharmacol; 2007 Jun 06; 27(3):302-3. PubMed ID: 17502779
    [No Abstract] [Full Text] [Related]

  • 31. Infections as complications of neuroleptic malignant syndrome.
    Bilanakis N, Peritogiannis V, Kalampokis G.
    World J Biol Psychiatry; 2009 Jun 06; 10(4 Pt 3):973-6. PubMed ID: 18609425
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Fatal complications of neuroleptic drugs. A clinico-pathological study of three cases.
    Surmont DW, Colardyn F, De Reuck J.
    Acta Neurol Belg; 1984 Jun 06; 84(2):75-83. PubMed ID: 6145281
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. AANA journal course. Update for nurse anesthetists. Neuroleptic malignant syndrome.
    Waldorf S.
    AANA J; 2003 Oct 06; 71(5):389-94. PubMed ID: 14625976
    [Abstract] [Full Text] [Related]

  • 36. Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
    Garrido SM, Chauncey TR.
    Bone Marrow Transplant; 1998 Feb 06; 21(4):427-8. PubMed ID: 9509981
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.